Literature DB >> 31342185

Non-invasive Risk Stratification for Coronary Artery Disease: Is It Time for Subclassifications?

Pupalan Iyngkaran1, Samer Noaman2, William Chan3, Gnanadevan Mahadavan4, Merlin C Thomas5, Sharmalar Rajendran4.   

Abstract

PURPOSE OF REVIEW: Coronary artery disease (CAD) is the leading contributor to cardiovascular disease; it is the most prevalent non-communicable disease globally and has high morbidity, mortality and health care cost. Risk stratification is defined as prevention or containment of disease prior to it occurring or progressing, and non-invasive surrogates include history, examination, biomarkers and non-invasive imaging. This review aims to highlight advancement in current diagnostic strategies and explores gaps for CAD secondary to atherosclerosis and non-obstructive vascular diseases. RECENT
FINDINGS: Cardiac risk scores have largely proven inadequate in risk stratifying heterogeneous patient populations. Greater emphasis should also be provided to posttest risk stratification. Non-invasive imaging with MRI is the most accurate but least cost efficacious presently due to availability and expertise. Echocardiography and nuclear imaging have good accuracy, but radiation limits the latter. Novel echocardiographic technologies may increase its appeal. Cardiac CT angiography is increasingly promising. Non-invasive and minimally invasive imaging has significantly influenced the cost-efficacy trajectory of coronary artery disease diagnosis and management. Recent studies suggest that future guidelines will incorporate more subclassifications from the findings of these novel technologies and for more diverse patient demographics.

Entities:  

Keywords:  Coronary artery disease; Cost efficacy; Minimal invasive imaging; Non-invasive imaging; Risk score; Risk stratification; Screening

Year:  2019        PMID: 31342185     DOI: 10.1007/s11886-019-1174-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  67 in total

Review 1.  Noninvasive surrogate markers of atherosclerosis.

Authors:  Steven B Feinstein; Paolo Voci; Francesco Pizzuto
Journal:  Am J Cardiol       Date:  2002-03-07       Impact factor: 2.778

2.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

3.  Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.

Authors:  T Heitzer; T Schlinzig; K Krohn; T Meinertz; T Münzel
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

4.  Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.

Authors:  R C Hoogeveen; J K Gambhir; D S Gambhir; K T Kimball; K Ghazzaly; J W Gaubatz; M Vaduganathan; R S Rao; M Koschinsky; J D Morrisett
Journal:  J Lipid Res       Date:  2001-04       Impact factor: 5.922

5.  Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.

Authors:  Marcelo F Di Carli; James Janisse; George Grunberger; Joel Ager
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

6.  Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; M di Terlizzi; K P Schäfers; T F Lüscher; P G Camici
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

7.  Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; K P Schäfers; T F Lüscher; P G Camici
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

8.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

Authors:  S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

9.  Prognostic value of coronary vascular endothelial dysfunction.

Authors:  Julian P J Halcox; William H Schenke; Gloria Zalos; Rita Mincemoyer; Abhiram Prasad; Myron A Waclawiw; Khaled R A Nour; Arshed A Quyyumi
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

10.  Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan.

Authors:  Olakunle O Akinboboye; Ru-Ling Chou; Steven R Bergmann
Journal:  J Am Coll Cardiol       Date:  2002-08-21       Impact factor: 24.094

View more
  3 in total

Review 1.  The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A Review.

Authors:  Soloman Saleh; Jacob George; Katharine A Kott; Peter J Meikle; Gemma A Figtree
Journal:  Front Cardiovasc Med       Date:  2022-06-02

2.  Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies.

Authors:  Kejun Ding; Zhewei Shi; Caizhen Qian; Xuan Yang
Journal:  Front Cardiovasc Med       Date:  2022-01-10

3.  Body fat percentage and CRP correlates with a composite score of vascular risk markers in healthy, young adults - The Lifestyle, Biomarkers, and Atherosclerosis (LBA) study.

Authors:  Paul Pettersson-Pablo; Yang Cao; Torbjörn Bäckström; Torbjörn K Nilsson; Anita Hurtig-Wennlöf
Journal:  BMC Cardiovasc Disord       Date:  2020-02-11       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.